Atossa Therapeutics
ATOS
ATOS
31 hedge funds and large institutions have $6.52M invested in Atossa Therapeutics in 2026 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
53% less funds holding
Funds holding: 66 → 31 (-35)
83% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 40
Holders
31
Holding in Top 10
–
Calls
$459K
Puts
$572K
Top Buyers
| 1 | +$418K | |
| 2 | +$76.6K | |
| 3 | +$35.5K | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$15.2K |
| 5 |
Jones Financial Companies
Des Peres,
Missouri
|
+$12.8K |
Top Sellers
| 1 | -$618K | |
| 2 | -$382K | |
| 3 | -$246K | |
| 4 |
Renaissance Technologies
New York
|
-$181K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$157K |
